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eplicating the large amount of DNA in eukaryotic cells is a complex task, requiring the activation of hundreds or thousands of origins spread throughout the genome. To maintain genetic stability, it is essential that during S phase genomic DNA is precisely duplicated, with no sections of DNA left unreplicated and no section of DNA replicated more than once. To prevent rereplication, cells divide the process of DNA replication into two non-overlapping phases. Prior to S phase, origins are licensed by the binding of minichromosome maintenance 2-7 (MCM2-7) double hexamers (Gillespie et al. 2001; Blow and Dutta 2005; Arias and Walter 2007) . During S phase, these are activated as the core of the CMG (Cdc45-MCM-GINS) replicative helicase (Moyer et al. 2006; Ilves et al. 2010) . Prior to the onset of S phase, licensing proteins are downregulated or inhibited, so that no more origins can be licensed (Wohlschlegel et al. 2000; Tada et al. 2001; Li et al. 2003; Li and Blow 2005) . One consequence of using this mechanism for preventing re-replication of DNA is that it is imperative that enough origins are licensed prior to S-phase entry, so that no regions of the genome remain unreplicated, even if some replication forks stall or some origins fail to initiate . Metazoan cells employ a licensing checkpoint to monitor that sufficient origins are licensed, inhibiting S-phase entry until this is established (Shreeram et al. 2002; Blow and Gillespie 2008 ).
Here we review recent research showing how cells ensure complete genome duplication by licensing more replication origins in G1 than are normally used during S phase. The otherwise dormant replication origins become important for ensuring the completion of DNA replication if replication forks stall or are inhibited during S phase. We also review research showing how the licensing checkpoint ensures that a large enough number of origins are licensed before cells embark on S phase.
DORMANT REPLICATION ORIGINS
MCM2-7 complexes are loaded onto DNA in excess over the number normally used, with only 10% being used in an unperturbed S phase (Burkhart et al. 1995; Donovan et al. 1997; Mahbubani et al. 1997; Blow et al. 2011; Wong et al. 2011) . The rest normally remain dormant and are passively replicated by oncoming forks (Woodward et al. 2006; Ge et al. 2007 ). Dormant origins are fully capable of initiating, but are not essential for normal S-phase progression (Woodward et al. 2006) . The existence of these dormant origins means that origin usage can change depending on the circumstance. Levels of chromatin-bound MCM2-7 can be reduced several-fold in Xenopus egg extracts, C. elegans, and in human cell lines without causing a significant effect on overall replication rates (Mahbubani et al. 1997; Edwards et al. 2002; Oehlmann et al. 2004; Ge et al. 2007; Ibarra et al. 2008) . However, these "minimally licensed" cells fail to complete replication when challenged with exogenous replicative stress, suggesting a role for dormant origins in overcoming such stresses (Woodward et al. 2006; Ge et al. 2007; Ibarra et al. 2008) .
Replication forks can be inhibited either by exposure to exogenous inhibitors or when they encounter impediments such as proteins tightly bound to DNA, chemically modified bases or DNA strand breaks. Often the problems can be overcome, and the inhibited forks can resume DNA synthesis. However, there are occasions where replication forks irreversibly collapse, which may be associated with the disassembly of replisome proteins from the DNA (Sirbu et al. 2011 ). Since new origins cannot be licensed after entry into S phase, cells must rely on previously licensed origins to overcome this issue. Replication forks travel bidirectionally, meaning that if a single fork stalls, a fork coming from the opposite direction can rescue this (Fig. 1A,B) . However, when two converging forks stall, the genome between them is left in a compromised state, and if there is no dormant origin between the stalled forks, completing DNA replication will be difficult (Fig. 1C) , possibly depending on recombination-dependent fork restart . However, if a dormant origin is activated between the stalled forks, this provides a simple mechanism for replication of all the intervening DNA ( Fig. 1D) (Woodward et al. 2006; Ge et al. 2007 ).
The exact mechanism for regulating dormant origins is unclear. It has been known for many years that in response to fork slowing, there is an increased density of origins within clusters (Ockey and Saffhill 1976; Taylor 1977; Francis et al. 1985; Griffiths and Ling 1985; Anglana et al. 2003; Ge et al. 2007; Gilbert 2007; Blow et al. 2011; Borowiec and Schildkraut 2011; Karnani and Dutta 2011) , indicating dormant origins have fired within these clusters. It is likely that firing of particular origins within a single cluster is a stochastic process, which can explain the observed cell-to-cell variation in origin use (Anglana et al. 2003; Blow and Ge 2009; Borowiec and Schildkraut 2011) . Since licensed origins are inactivated when they are passively replicated by oncoming forks, they are normally inactivated before they have time to initiate. Therefore, a reduction in fork elongation rate increases the length of time before inactivation of dormant origins, increasing the probability that they will initiate. Computer simulation of a 250-kb origin cluster showed that stochastic firing of origins can provide a good approximation to observed patterns of dormant origin firing if there are 3 dormant origins for each origin that fires under unstressed conditions (Blow and Ge 2009 ). The model also shows how dormant origins can allow replication to complete even if some forks stall irreversibly. This provides a simple explanation for how replication origin firing is regulated, which D. McIntosh and J.J. Blow simultaneously provides protection against replicative stress while minimizing the cost of using large numbers of replication forks (Blow and Ge 2009; Blow et al. 2011) . Consistent with this interpretation, there is a correlation between the degree of fork slowing and the overall increase in origin density (Ge et al. 2007; Courbet et al. 2008) .
Although dormant origin firing can occur as a consequence of purely stochastic processes, it is likely that it is also modulated by other regulatory mechanisms. In response to fork stalling, the DNA damage kinases ATR and Chk1 are activated (Branzei and Foiani 2005; Lambert and Carr 2005) . Inhibition of ATR or Chk1 results in an increase in origin density, even in the absence of stress (Miao et al. 2003; Marheineke and Hyrien 2004; Syljuasen et al. 2005; Woodward et al. 2006; Ge et al. 2007; Karnani and Dutta 2011) . One explanation for this behavior is that dormant origins are activated as a consequence of increased fork stalling that occurs in the absence of normal ATR and Chk1 activity (Zachos et al. 2003) . However, it is also possible that the low levels ATR/Chk1 active even in the absence of exogenous replicative stresses, play a role in suppressing dormant origins. In addition, low levels of Chk1 preferentially suppresses new origin firing in clusters yet to engage in replication, allowing dormant origins the chance to initiate in the clusters where fork stalling has occurred (see next section).
Once cells have progressed through S phase in the presence of replicative stresses, there is evidence that the usage of origins in the next S phase will be changed (Courbet et al. 2008) . After growing cells under conditions in which forks could only move slowly, which promoted a high rate of initiation at dormant origins, cells were synchronized in mitosis and replated into fresh medium that allowed fast fork progression. In the first S phase after replating, the overall initiation density dropped, as expected by the stochastic mechanism described above. When a particular locus around the AMPD gene was examined, initiation did not occur predominantly at what is normally the most efficient origin, oriGNAI3, but was distributed among the dormant origins as well as oriGNAI3. Only in the second S phase after the increase in fork speed was the dominance of oriGNAI3 regained and the relative efficiency of the dormant origins decreased. Therefore, it appears that cells acquire a memory of dormant origin use and can adapt to replicative stress by raising the efficiency of origins that are normally dormant (less efficient) (Blow and Ge 2008; Courbet et al. 2008) .
The use of dormant origins probably provides the first line of defense against slowed fork elongation and fork stalling. The importance of dormant origins in ensuring genome stability has been shown by their role in suppressing tumorigenesis. Mice hypomorphic for either MCM2 or MCM4 have reduced levels of chromatin-bound MCM2-7, resulting in a reduction in the number of dormant origins (Pruitt et al. 2007; Shima et al. 2007; Kunnev et al. 2010; Kawabata et al. 2011; Klotz-Noack and Blow 2011) . Cells from MCM hypomorphic mice suffer from increased fork stalling and increased Rad51 and FancD2 foci, indicative of DNA damage, even in the absence of exogenous stress (Kunnev et al. 2010; Kawabata et al. 2011) . These mice fail to deal normally with spontaneous damage caused by endogenous factors and this is likely to explain their dramatic increase in tumor formation. This suggests that dormant origins play an important role as tumor suppressors and that failure to activate dormant origins in response to endogenous replicative stresses can result in DNA damage and tumor formation.
REPLICATION FACTORIES
In metazoan cells, clusters of 2-5 adjacent origins initiate simultaneously during S phase (Jackson and Pombo 1998; Gillespie and Blow 2010) . One or more clusters are arranged into DNA domains comprising 1 Mb of DNA and roughly 6-12 replicons, each replicon typically replicating 50 -150 kb. Different clusters of origins initiate at varying times throughout S phase, giving rise to a timing program (Dimitrova and Gilbert 1999; Zink 2006) . The DNA within each domain can be visualized as individual foci, thousands of which can be visualized during each S phase. As each focus becomes activated for replication, it becomes associated with replication proteins to form a replication factory (Hozak et al. 1993; Leonhardt et al. 2000; Kitamura et al. 2006) . Early S-phase factories are all similar in size with a diameter of roughly 150 nm, and similar numbers are detected in all early S-phase nuclei . It is currently unknown if factories are physical structures where the fork proteins are organized into a superstructure or whether the foci as formed as a result of the organization of the DNA into higher-order chromatin structure.
It has recently been shown that these factories are regulated in response to replicative stresses. In response to low levels of replicative stress, there is an increase in the number of replication forks per factory that corresponds to the activation of dormant origins (Ge and Blow 2010) . This increase in initiation leads to the increased fork density seen by DNA fiber analysis. If the overall rate of replication of DNA domains were reduced by replication fork inhibition, and if the rate at which new factories are activated were to remain constant, the result should be an increase in the number of active factories. However, the opposite is actually observed: inhibition of replication forks causes a reduction in the number of active factories (Cseresnyes et al. 2009; Ge and Blow 2010) . Experiments examining factory dynamics after replication forks are inhibited showed that the reduction in factory number is a result of a reduction in the rate at which new replication factories are activated and depends on Chk1 (Fig. 2) (Ge and Blow 2010) . ATR is activated in response to slowed fork progression or stalling and in turn activates Chk1 kinase activity (Branzei and Foiani 2005; Lambert and Carr 2005) . By preferentially inhibiting the activation of new replication factories, Chk1 Very little is known about how replication factories are regulated and it is currently not known how Chk1 is able to distinguish between active clusters and those already replicating. The activation of new factories is highly sensitive to varying cyclin-dependent kinase (CDK) activity. When CDK activity was reduced using the drug roscovitine, the number of factories was also reduced (Thomson et al. 2010) . Two different possibilities have been proposed to explain this effect (Ge and Blow 2010; Gillespie and Blow 2010; Thomson et al. 2010; Blow et al. 2011) . CDKs are directly required for individual replication origins to fire, and it is possible that the firing of the first origin within a cluster might propagate a change throughout the cluster to facilitate initiation at other origins within the cluster. A reduction in CDK level would lower the overall initiation rate and thereby reduce the activation of new factories. Downstream targets of Chk1, such as p53 and Cdc25 could reduce CDK activity and thereby reduce the rate of activation of new factories. An alternative possibility is that CDK activity plays a direct role in factory regulation, by phosphorylating factoryspecific substrates (such as, for example, proteins involved in chromatin remodeling) distinct from substrates that are required for the firing of individual origins. These factory-specific substrates might then be directly inhibited by Chk1 in response to replicative stresses (Ge and Blow 2010; Gillespie and Blow 2010; Thomson et al. 2010; Blow et al. 2011) .
The regulation of replication at the factory level is important for ensuring that the genome is completely replicated. By preferentially inhibiting the activation of new replication factories, Chk1 can still allow dormant origins to fire stochastically in factories that are experiencing replicative stress. This effectively directs replication activity to regions of the genome encountering stress, by activating dormant origins in factories where forks are encountering problems. Correct regulation of this process requires the proper operation of DNA damage and cell cycle checkpoint responses. As these systems are often compromised in cancer cells, they may be unable to correctly regulate dormant origins and replication factories when replication fork progress is inhibited. It is possible that this may explain the sensitivity of some cancer cells to chemotherapeutic drugs that target the process of DNA replication Blow et al. 2011) . It is also possible that chromosome fragile sites, which are prone to breakage as a result of replication fork failure, represent regions where dormant origins are either inefficiently licensed or inefficiently activated (Letessier et al. 2011; Ozeri-Galai et al. 2011; Debatisse et al. 2012) . 
THE LICENSING CHECKPOINT
To prevent re-replication of regions of chromosomal DNA, it is essential that once cells pass the G1-S-phase boundary, no further origins are licensed (Blow and Dutta 2005; Arias and Walter 2007) . Entering S phase with too few origins would result in a reduced number of dormant origins and would require forks to replicate longer sections of DNA without stalling (Blow and Ge 2009 ). It would therefore be better for cells to delay entry into S phase if they do not have a sufficiently large number of licensed origins. It has been shown that several different cell types employ a "licensing checkpoint" to achieve this (Shreeram et al. 2002; Gillespie et al. 2007; Blow and Gillespie 2008) . The S phase delay characteristic of the licensing checkpoint has been observed when the loading of MCM2-7 onto DNA is reduced in a range of different ways: by knockdown of ORC, Cdc6 Ctd1 or MCM2-7 by RNAi, or inhibition of Cdt1 by geminin (Shreeram et al. 2002; Feng et al. 2003; Machida et al. 2005; Gillespie et al. 2007; Liu et al. 2009; Nevis et al. 2009 ). Many cancer cells are defective in this checkpoint and can enter S phase despite a severe reduction in the number of origins that have been licensed (Shreeram et al. 2002; Feng et al. 2003; Liu et al. 2009; Nevis et al. 2009 ), a feature that may contribute to the genetic instability typically detected in cancer cells (Fig. 3 ) . Under normal circumstances, progression through the restriction point into S phase depends on the CDK-dependent phosphorylation of Rb, which abolishes its inhibition of E2F and promotes transcription of S-phase genes. The G1 arrest observed in cells that have engaged the licensing checkpoint is associated with low CDK4/6-Cyclin D activity, low CDK2-Cyclin E activity and Rb hypophosphorylation, suggesting that the licensing checkpoint prevents progression through the restriction point (Fig. 4 ) (Shreeram et al. 2002; Machida et al. 2005; Teer et al. 2006; Liu et al. 2009; Nevis et al. 2009 ). The way that the degree of licensing is sensed by the checkpoint is currently unknown, but it appears to converge on CDK down-regulation by several different routes. One common route appears to be the p53-dependent activation of CDK
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Cip1 and p27 Kip1 (Shreeram et al. 2002; Machida et al. 2005; Teer et al. 2006; Liu et al. 2009 ). A second p53-dependent pathway involves loss of phosphorylation at Thr160 in the activation T loop of CDK2, accompanied by delayed nuclear accumulation of CDK2 protein in late G1 ). Depletion of p53 in primary cells abolished the licensing checkpoint, promoting Rb hyperphosphorylation and E2F transcriptional activity. There also appears to be other p53-independent mechanisms by which CDK activity is reduced when the licensing checkpoint is engaged, as RNAi knockdown of components of the licensing system directly suppressed cyclin D1 transcription and lowered CDK4/6 kinase activity (Liu et al. 2009) . Another way by which defective origin licensing delays S-phase CDK activation has been demonstrated in Xenopus egg extract. The nucleoporin ELYS associates with MCM2-7 on chromatin and if licensing is inhibited (for example, by geminin addition or MCM2-7 depletion), the association of ELYS with chromatin is delayed (Gillespie et al. 2007; Khoudoli et al. 2008) . Since ELYS is required on chromatin for nuclear envelope formation, it is ultimately required for CDK activation, the initiation of DNA replication, and the activation of geminin, thereby creating a feed-forward loop to promote S-phase progression only once adequate origin licensing has occurred.
Mutations in genes encoding pre-RC proteins required for replication licensing (ORC1, ORC4, ORC6, CDT1, and CDC6) have been identified in patients with the genetic disorder Meier-Gorlin syndrome (Bicknell et al. 2011a,b; Klingseisen and Jackson 2011; de Munnik et al. 2012; Kuo et al. 2012) . Cells from these patients have a delayed G1 progression, most likely due to the activation of the licensing checkpoint, and a prolonged S phase. These delays in cell cycle progression result in reduced cell numbers, potentially explaining the primordial dwarfism phenotype. This provides evidence that the licensing checkpoint is operational in humans. It is currently unclear why humans with Meier-Gorlin syndrome show cell proliferation defects while mice hypomorphic for MCM2-7 are cancer-prone. One possibility is that this represents a difference between mice and humans. Alternatively, the licensing checkpoint might respond less strongly to defects in MCM2-7 than to defects in other pre-RC proteins (ORC, Cdc6, or Cdt1) . A third possibility is that the licensing defect in the MCM2-7 hypomorphic mice might be weaker than in Meier-Gorlin syndrome and may not be severe enough to reproducibly activate the licensing checkpoint (Klotz-Noack and Blow 2011). Indeed, MCM2-7 hypomorphic mice do show some defects in cell proliferation associated with a reduction in the number of stem cells (Pruitt et al. 2007) .
The reliance of the licensing checkpoint on p53 and Rb control systems that are often lost in cancer cells can potentially explain why the licensing checkpoint is not operational in cancerderived cell lines. Since E2F cannot be repressed by the licensing checkpoint, cancer cells lose the ability to inhibit progression into S phase. Defects in the licensing checkpoint could contribute to the genomic instability often detected in cancer cells, as cells entering S phase with too few origins have increased chances of fork stalling and DNA damage. The lack of licensing checkpoint in cancer cells also makes it a good anti-cancer target (Shreeram et al. 2002; Blow and Gillespie 2008) . Small-molecule inhibitors of the replication licensing system would kill cancer cells by allowing them to progress into S phase with an insufficient number of licensed origins. Normal cells would instead activate the licensing checkpoint and arrest temporarily in G1-like state, from where they could resume cell cycle progression once the drug is removed or metabolized.
